Keyphrases
Tourette Syndrome
100%
Parkinson's Disease
47%
Tic Disorders
36%
Levodopa
34%
Dopamine
20%
Tic Suppression
19%
D2 Receptor
17%
Neuroimaging
17%
Baboon
17%
Regional Cerebral Blood Flow (rCBF)
17%
Functional Magnetic Resonance Imaging
15%
Basal Ganglia
13%
Positron Emission Tomography
13%
Receptor Binding
12%
Provisional Tic Disorder
12%
Pathophysiology
11%
Putamen
11%
Striatal
11%
Dopamine D2 Receptor (DRD2)
11%
Nonhuman Primate
10%
Parkinsonism
10%
Tic Severity
10%
Chronic Tic Disorder
10%
Parkinson Patients
9%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
9%
Blood Flow
9%
Movement Disorders
9%
Blinking
9%
Flow Response
8%
Magnetic Resonance Imaging
8%
Functional Tics
8%
Brain Structure
8%
Pharmacodynamics
8%
Pharmacological MRI (phMRI)
7%
Specific Binding
7%
Placebo
7%
Randomized Placebo-controlled Trial
7%
Template Image
7%
Pediatric
7%
Type 1 Diabetes Mellitus (T1DM)
7%
Type I Diabetes
7%
Hippocampal Volume
7%
Psychosis
7%
Obesity
7%
Deep Brain Stimulation
7%
Radioligand
7%
Dopamine Agonist
6%
Image Registration
6%
Cerebral Blood Flow
6%
Focal Dystonia
6%
Neuroscience
Tic Disorder
83%
Tourette Syndrome
62%
Parkinson's Disease
52%
L-DOPA
32%
Functional Magnetic Resonance Imaging
19%
Positron Emission Tomography
16%
Receptor
13%
Basal Ganglia
13%
Magnetic Resonance Imaging
12%
Placebo
12%
Receptor Binding
12%
Dystonia
11%
Behavior (Neuroscience)
11%
Putamen
11%
Positron Emission Tomography
10%
Magnetic Resonance Imaging
10%
Parkinsonism
9%
Thalamus
9%
Electrical Brain Stimulation
9%
Dopamine Receptor D2
8%
Agonist
8%
Stereotypic Movement Disorder
8%
In Vivo
8%
Subthalamic Nucleus
7%
Dopaminergic
7%
DNA Template
7%
Dopamine Agonist
7%
Hypoglycemia
6%
Fluorine-18
6%
Body Mass Index
6%
Radioligand
6%
Typical Antipsychotic
6%
Functional Connectivity
6%
Hyperglycemia
6%
Arterial Spin Labeling
5%
Frontal Lobe
5%
Pimavanserin
5%
Substantia nigra
5%